Maxadilan prevents apoptosis in iPS cells and shows no effects on the pluripotent state or karyotype.
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a structurally endogenous peptide with many biological roles. Maxadilan, a 61-amino acid vasodilatory peptide, specifically activates the PACAP type I receptor (PAC1). Although PAC1 has been identified in embryonic stem cells, little is k...
Main Authors: | Zhiyi Zhao, Rongjie Yu, Jiayin Yang, Xiaofei Liu, Meihua Tan, Hongyang Li, Jiansu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3311553?pdf=render |
Similar Items
-
Modulation of pluripotency in the porcine embryo and iPS cells.
by: Aida Rodríguez, et al.
Published: (2012-01-01) -
Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
by: Lieke Joosten, et al.
Published: (2017-05-01) -
Induced Pluripotent Stem (iPS) Cell Research Overview
by: Shih-Ping Liu, et al.
Published: (2011-02-01) -
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
by: Mungenast, Alison, et al.
Published: (2017) -
An ES-like pluripotent state in FGF-dependent murine iPS cells.
by: Bruno Di Stefano, et al.
Published: (2010-12-01)